HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of angiotensinogen gene M235T polymorphism with the risk of IgA nephropathy: a meta-analysis.

Abstract
The association between angiotensinogen (AGT) M235T gene polymorphism and IgA nephropathy (IgAN) risk remains elusive. Our aim was to evaluate the association between AGT M235T gene polymorphism and IgAN susceptibility by performing a meta-analysis. Eligible studies were searched according to predefined criteria using electronic databases. Eight studies were identified for the analysis of the association between AGT M235T gene polymorphism and IgAN risk. M allele/MM genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.448 and 0.861, Caucasians: p = 0.618 and 0.886, Asians: p = 0.566 and 0.652). TT/MT genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.703 and 0.454, Caucasians: p = 0.975 and 0.946, Asians: p = 0.697 and 0.353). No evidence of publication bias was observed. In conclusion, AGT M235T gene polymorphism may not be correlated with IgAN susceptibility in overall populations, Caucasians and Asians. However, more studies should be performed in the future.
AuthorsSong Mao, Songming Huang
JournalRenal failure (Ren Fail) Vol. 36 Issue 3 Pg. 466-72 (Apr 2014) ISSN: 1525-6049 [Electronic] England
PMID24344785 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensinogen
  • Threonine
  • Methionine
Topics
  • Alleles
  • Angiotensinogen (genetics)
  • Asian People (genetics)
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Glomerulonephritis, IGA (genetics)
  • Humans
  • Methionine (genetics)
  • Polymorphism, Genetic
  • Risk Factors
  • Threonine (genetics)
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: